Androgen treatment without inhibiting effect on hypophysis and male gonads. Biochemical and morphological studies after treatment with Mesterolone.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000728:Androgens / Q000494:pharmacology* / Q000627:therapeutic use; D002624:Chemistry, Clinical; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D007172:Erectile Dysfunction / Q000188:drug therapy; D005938:Glucocorticoids / Q000652:urine; D006062:Gonadotropins / Q000652:urine; D006065:Gonadotropins, Pituitary / Q000378:metabolism; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects*; D013094:Spermatozoa; D013737:Testis / Q000187:drug effects* / Q000473:pathology
D015068:17-Ketosteroids; D000728:Androgens; D005938:Glucocorticoids; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary